BioSpace News Archive

M400s being used to stream patient surgeries for up to 16 hours for education and training purposes

Alimera Sciences, Inc., a pharmaceutical company that specializes in the development and commercialization of prescription ophthalmic pharmaceuticals, announces that Rick Eiswirth, President and Chief Executive Officer, will present a corporate overview at the H. C. Wainwright and Company 22nd Annual Global Virtual Investor Conference on Tuesday September 15, 2020 at 3:30 PM ET.

Orexo and GoGoMeds have formed a partnership to make the scientifically-proven, digital therapies deprexis® and vorvida® available for the treatment of depression and management of problematic alcohol misuse respectively.

Capital Health confirms its role as a nationally recognized health care leader with world-class expertise and advanced technology.

Since 2000 more than 6 million robotic-assisted surgeries have taken place across multiple medical specialties including Cardiovascular, Neurology, and Orthopedics.

Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced that Executive Chairman Robert J. Coury, together with President Rajiv Malik will present at the BofA Securities Virtual Global Healthcare Conference on Thursday, Sep. 17, 2020, at 10:05 a.m. ET/ 3:05 p.m. BST.

EmergeOrtho—Triangle Region welcomes Dr. Daniel Carpenter to the Wilson practice, starting September 1, 2020. As a board-eligible and fellowship-trained surgeon, Dr. Carpenter brings his extensive experience and specialized skills to not one, but three subspecialty orthopedic teams—Shoulder, Elbow and Arm, and General Orthopedics.

Immune Regulation Ltd, a US and UK based clinical stage biotechnology company, today announced that it has received a notice of allowance from the U.S. Patent and Trademark Office (USPTO) for a new patent covering IRL201805 (‘1805).

Virtual #NCCNPolicy Summit features congressional staffers and representatives from CMS, COA, BIO, discussing legislative and regulatory approaches for reducing health care costs.

In August 2020, Fotona, based in Europe and the U.S., completed the purchase of the Fox III and Fox IV lasers systems and the EmunDo® Therapy system from A.R.C. Laser GmbH.